Dove DermaSeries Eczema Therapy Cream
- Manufacturer
- Conopco Inc. d/b/a Unilever
- Effective date
- 2022-12-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-05-31 23:52:03
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient
Colloidal Oatmeal (1.0%)
OTC - PURPOSE SECTION
Purpose
Skin protectant
INDICATIONS & USAGE SECTION
Uses
Temporarily protects and helps relieve minor skin irritation and itching due to: ● eczema rashes
WARNINGS SECTION
WARNINGS
For External Use Only.
OTC - WHEN USING SECTION
When using this product do not get into eyes.
OTC - STOP USE SECTION
Stop use and ask a doctor if ● condition worsens ● symptoms last more than 7 days or clear up and occur again within a few days
OTC - DO NOT USE SECTION
Do not use on
● deep or puncture wounds
● animal bites
● serious burns
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center immediately.
DOSAGE & ADMINISTRATION SECTION
Directions
● apply as needed.
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Water (Aqua), Glycerin, Dimethicone, Hydroxystearic Acid, Sodium Hydroxypropyl Starch Phosphate, Isopropyl Myristate, Petrolatum, Cetearyl Alcohol, Glyceryl Hydroxystearate, Caprylyl Glycol, Phenoxyethanol, Stearic Acid, Citrus Limon (Lemon) Peel Powder, Cetearyl Glucoside, Citrus Aurantifolia (Lime) Peel Powder, Disodium EDTA, Titanium Dioxide (CI 77891).
OTC - QUESTIONS SECTION
Questions or comments?
Call 1-800-761-DOVE (3683)
4.1 FL. OZ. PDP
4.1 Fl. OZ. Carton
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 240651 | colloidal oatmeal 1 % Topical Cream | PSN | 4 |
| 1440026 | Dove DermaSeries Eczema 1 % Topical Cream | PSN | 4 |
| 1440026 | colloidal oatmeal 10 MG/ML Topical Cream [Dove DermaSeries Eczema] | SBD | 4 |
| 240651 | colloidal oatmeal 10 MG/ML Topical Cream | SCD | 4 |
| 240651 | Avena sativa 1 % Topical Cream | SY | 4 |
| 240651 | colloidal oatmeal 1 % Topical Cream | SY | 4 |
| 1440026 | Dove DermaSeries Eczema 1 % Topical Cream | SY | 4 |
| 1440026 | Dove DermaSeries Eczema 10 MG/ML Topical Cream | SY | 4 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| OATMEAL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20181113 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64942-1306-2 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-131e-f424-e053-dadaa90a57ce | Dove DermaSeries Eczema Therapy Cream |
| 64942-1306-3 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-131e-f424-e053-dadaa90a57ce | Dove DermaSeries Eczema Therapy Cream |
| 64942-1306-2 | 2021-04-13 | C162847 | 48780-1 | 9d75b9d0-131e-f424-e053-dadaa90a57ce | Dove DermaSeries Eczema Therapy Cream |
| 64942-1306-3 | 2021-04-13 | C162847 | 48780-1 | 9d75b9d0-131e-f424-e053-dadaa90a57ce | Dove DermaSeries Eczema Therapy Cream |
| 64942-1306-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-131e-f424-e053-dadaa90a57ce | Dove DermaSeries Eczema Therapy Cream |
| 64942-1306-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-131e-f424-e053-dadaa90a57ce | Dove DermaSeries Eczema Therapy Cream |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64942-1306-1 | Dove DermaSeriesEczema Therapy Cream | 120 mL in 1 TUBE | CREAM | 120 | 4 | |
| 64942-1306-2 | Dove DermaSeriesEczema Therapy Cream | 1 in 1 CARTON | CREAM | 1 | 4 | |
| 64942-1306-3 | Dove DermaSeriesEczema Therapy Cream | 15 mL in 1 TUBE | CREAM | 15 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64942-1306 | DOVE DERMASERIES ECZEMA THERAPY CREAM (OATMEAL) CREAM [CONOPCO INC. D/B/A UNILEVER] | 4 | Legacy NDC, 3 package rows | 20221206_6982a511-5d4f-472e-8e4f-ee250aff3d4f.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OATMEAL | ACTIVE INGREDIENT | 8PI54V663Y | 1 | |
| OATMEAL | ACTIVE MOIETY | 8PI54V663Y | 1 | |
| 12-HYDROXYSTEARIC ACID | INACTIVE INGREDIENT | 933ANU3H2S | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CETEARYL GLUCOSIDE | INACTIVE INGREDIENT | 09FUA47KNA | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| ISOPROPYL MYRISTATE | INACTIVE INGREDIENT | 0RE8K4LNJS | 1 | |
| LEMON PEEL | INACTIVE INGREDIENT | 72O054U628 | 1 | |
| LIME PEEL | INACTIVE INGREDIENT | 544EQK5Q0W | 1 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Dove DermaSeries Eczema Therapy Cream
- Oatmeal
- WATER
- GLYCERIN
- DIMETHICONE
- 12-HYDROXYSTEARIC ACID
- ISOPROPYL MYRISTATE
- PETROLATUM
- CETOSTEARYL ALCOHOL
- CAPRYLYL GLYCOL
- PHENOXYETHANOL
- STEARIC ACID
- LEMON PEEL
- CETEARYL GLUCOSIDE
- LIME PEEL
- EDETATE DISODIUM
- TITANIUM DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64942-1306 | 64942-1306-1, 64942-1306-2, 64942-1306-3 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| DIMETHICONE | 92RU3N3Y1O | IACT |
| 12-HYDROXYSTEARIC ACID | 933ANU3H2S | IACT |
| ISOPROPYL MYRISTATE | 0RE8K4LNJS | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| CETOSTEARYL ALCOHOL | 2DMT128M1S | IACT |
| CAPRYLYL GLYCOL | 00YIU5438U | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| LEMON PEEL | 72O054U628 | IACT |
| CETEARYL GLUCOSIDE | 09FUA47KNA | IACT |
| LIME PEEL | 544EQK5Q0W | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| OATMEAL | 8PI54V663Y | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRABURSAL | 0.01 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRALESIONAL | 0.05 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, SOLUBLE / ORAL | 2 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / TOPICAL | 0.11 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYSTEM / TOPICAL | 126 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL / TRANSDERMAL | 85 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | 80 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / ORAL | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, CHEWABLE / ORAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAVENOUS | 7 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM / BUCCAL | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRA-ARTICULAR | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION/ DROPS / OPHTHALMIC | 0.13 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | GRANULE, FOR SUSPENSION / ORAL | 143 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / TOPICAL | 24 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / NASAL | 100 mg/100ml | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SHAMPOO, SUSPENSION / TOPICAL | 3 %w/v | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, DELAYED RELEASE / ORAL | 66 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / ORAL | 30 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.4 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / TOPICAL | 1428 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ef195fee-89c8-6c8f-e053-2995a90a8b29 | 6982a511-5d4f-472e-8e4f-ee250aff3d4f | 2022-12-05 | Warnings | ef195fee-89c8-6c8f-e053-2995a90a8b29 6982a511-5d4f-472e-8e4f-ee250aff3d4f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

